Exploring Low‐Intensity Focused‐ultrasound Neuromodulation in Alzheimer's Disease
These preliminary findings suggest that LIFU neuromodulation is safe and may offer cognitive benefits for individuals with amyloid-positive MCI. This study highlights the promise of FUS technology as a novel adjuvant therapeutic approach in AD.
Authors
- Ali R. Rezai (ORCID: https://orcid.org/0000-0002-7780-0378)
- Tasneem Arsiwala (ORCID: https://orcid.org/0000-0002-5799-0514)
- Geoffrey G. Adams (ORCID: https://orcid.org/0000-0002-8975-1593)
- Marc W. Haut (ORCID: https://orcid.org/0000-0003-0235-362X)
- Manish Ranjan (ORCID: https://orcid.org/0000-0002-3338-8676)
- Victor Finomore
- Camila Vieira Ligo Teixeira
Institutions
- West Virginia University (US)
- Blanchette Rockefeller Neurosciences Institute (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70858_100580
- Primary Topic
- Ultrasound and Hyperthermia Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00